Effective combination of minocycline and interferon-β in a model of multiple sclerosis

The objective of the current study was to investigate whether minocycline improves the effect of an existing multiple sclerosis (MS) medication, interferon-β, on experimental autoimmune encephalomyelitis (EAE) in mice. When used at sub-optimal doses, neither medication affected EAE but their combination at these doses led to the significant alleviation of EAE disease severity scores and histological outcomes. In culture, the toxicity of T cells to neurons was alleviated by their prior exposure to minocycline or interferon-β and their combination further attenuated neuronal death. Collectively, these results suggest the utility of the combination of minocycline and interferon-β in MS.